CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010
Cash Flows From Operating Activities :
Net loss	$ (7,054,278)	$ (5,076,215)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,908,650	2,258,494
Stock options issued to consultants for services	46,000	83,284
Stock-based compensation expense related to employee options and restricted stock	139,563	293,232
Provision for bad debts	0	53,205
Loss on disposal of assets	938	0
Change in estimated fair value of warrant liability	1,310,410	97,956
Changes in operating assets and liabilities:
Accounts receivable	398,756	795,373
Inventories	(1,389,518)	425,575
Prepaid expenses and other assets	670,529	344,172
Accounts payable	1,649,732	(361,963)
Accrued compensation and related expenses	(190,853)	(257,769)
Other accrued liabilities	736,874	6,395
Interest accrued on convertible debt	1,061,866	911,104
Deferred revenues	232,246	27,283
Net cash used in operating activities	(479,085)	(399,874)
Cash Flows From Investing Activities:
Purchases of property and equipment	(56,667)	(79,848)
Lasers placed into service, net	261,930	(926,749)
Acquisition costs, net of cash received	0	(96,514)
Net cash provided by (used in) investing activities	205,263	(1,103,111)
Cash Flows From Financing Activities:
Registration costs	0	(752,875)
Payments on notes payable	(102,881)	(205,707)
Proceeds from issuance of common stock, net	88,548	3,204,000
Proceeds from term debt	0	2,500,000
Repayments on line of credit	(592,800)	(1,797,114)
Proceeds from option exercise	1,036	0
Cash released from restriction	0	39,000
Net cash(used in) provided by financing activities	(606,097)	2,987,304
Effect of exchange rate changes on cash	6,599	65,533
Net (decrease) increase in cash and cash equivalents	(873,320)	1,549,852
Cash and cash equivalents, beginning of period	3,523,948	2,116,788
Cash and cash equivalents, end of period	$ 2,650,628	$ 3,666,640